Literature DB >> 10325396

Emergence of carbapenem-hydrolyzing enzymes in Acinetobacter baumannii clinical isolates.

G J Da Silva1, G J Leitão, L Peixe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10325396      PMCID： PMC85053     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  9 in total

Review 1.  Acinetobacter species as nosocomial pathogens.

Authors:  D H Forster; F D Daschner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-02       Impact factor: 3.267

2.  Acinetobacter spp. isolates with reduced susceptibilities to carbapenems in a UK burns unit.

Authors:  M J Weinbren; A P Johnson; M E Kaufmann; D M Livermore
Journal:  J Antimicrob Chemother       Date:  1998-05       Impact factor: 5.790

3.  Imipenem resistance among Acinetobacter baumannii: association with reduced expression of a 33-36 kDa outer membrane protein.

Authors:  R B Clark
Journal:  J Antimicrob Chemother       Date:  1996-08       Impact factor: 5.790

Review 4.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

Review 5.  Metallo-beta-lactamases: a class apart.

Authors:  K Bush
Journal:  Clin Infect Dis       Date:  1998-08       Impact factor: 9.079

6.  Antimicrobial susceptibility of Acinetobacter species.

Authors:  H Seifert; R Baginski; A Schulze; G Pulverer
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

7.  Imipenem resistance in Acinetobacter baumanii is due to altered penicillin-binding proteins.

Authors:  M Gehrlein; H Leying; W Cullmann; S Wendt; W Opferkuch
Journal:  Chemotherapy       Date:  1991       Impact factor: 2.544

8.  In vitro antimicrobial production of beta-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii.

Authors:  J Vila; A Marcos; F Marco; S Abdalla; Y Vergara; R Reig; R Gomez-Lus; T Jimenez de Anta
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

9.  ARI 1: beta-lactamase-mediated imipenem resistance in Acinetobacter baumannii.

Authors:  R Paton; R S Miles; J Hood; S G Amyes; R S Miles; S G Amyes
Journal:  Int J Antimicrob Agents       Date:  1993-02       Impact factor: 5.283
  9 in total
  18 in total

1.  Identification of residues critical for metallo-beta-lactamase function by codon randomization and selection.

Authors:  I C Materon; T Palzkill
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

2.  Channel formation by CarO, the carbapenem resistance-associated outer membrane protein of Acinetobacter baumannii.

Authors:  Axel Siroy; Virginie Molle; Christelle Lemaître-Guillier; David Vallenet; Martine Pestel-Caron; Alain J Cozzone; Thierry Jouenne; Emmanuelle Dé
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

3.  Characterization of genetic diversity of carbapenem-resistant Acinetobacter baumannii clinical strains collected from 2004 to 2007.

Authors:  Chao Qi; Michael Malczynski; Michelle Parker; Marc H Scheetz
Journal:  J Clin Microbiol       Date:  2008-01-23       Impact factor: 5.948

4.  Characterization of the metallo-beta-lactamase determinant of Acinetobacter baumannii AC-54/97 reveals the existence of bla(IMP) allelic variants carried by gene cassettes of different phylogeny.

Authors:  M L Riccio; N Franceschini; L Boschi; B Caravelli; G Cornaglia; R Fontana; G Amicosante; G M Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

5.  Molecular and biochemical heterogeneity of class B carbapenem-hydrolyzing beta-lactamases in Chryseobacterium meningosepticum.

Authors:  S Bellais; D Aubert; T Naas; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

Review 6.  Metallo-beta-lactamases: the quiet before the storm?

Authors:  Timothy R Walsh; Mark A Toleman; Laurent Poirel; Patrice Nordmann
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

7.  Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases.

Authors:  G Bou; G Cerveró; M A Domínguez; C Quereda; J Martínez-Beltrán
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

8.  The molecular epidemiological study of colistin-only-sensitive strains in multi-drug resistant Acinetobacter baumannii.

Authors:  Li Yang; Lizhong Han; Jingyong Sun; Yunsong Yu; Yuxing Ni
Journal:  Front Med China       Date:  2007-10

9.  Evaluation of a new Etest for detecting metallo-beta-lactamases in routine clinical testing.

Authors:  Timothy R Walsh; Anne Bolmström; Anette Qwärnström; Ana Gales
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

10.  Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan.

Authors:  Po-Ren Hsueh; Lee-Jene Teng; Cheng-Yi Chen; Wen-Hwei Chen; Chong-Jen Yu; Shen-Wu Ho; Kwen-Tay Luh
Journal:  Emerg Infect Dis       Date:  2002-08       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.